// App-Quantinova.ai

1332 : The Extracellular Matrix Derived From Human Cirrhotic Liver Strongly Reduces The Anti‐Cancer Immune Response in a 3D Model Of Hepatocellular Carcinoma

Researchers

Presenter

  • Maria Giovanna Vilia

Principal Investigators

  • Walid Al-Akkad

  • Elisabetta Caon

  • Andrew R Hall

  • Tuvinh Luong

  • Krista Rombouts

  • Massimo Pinzani

  • Giuseppe Mazza

Medical Centers

  • Institute for Liver and Digestive health, The Royal Free Hospital and University College London, London, United Kingdom

  • Institute for Liver and Digestive Disease, University College London,

  • Institute for Liver and Digestive Disease, University College London,

  • University College London Medical School, London, UK,

  • University College London, Division of Medicine, Institute for Liver and Digestive Health, Royal Free Hospital, London, United Kingdom,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved